Bioreducible Hyperbranched Poly(amido Amine)s for Gene Delivery
Overview
Biology
Molecular Biology
Authors
Affiliations
A series of reducible hyperbranched poly(amido amine)s (RHB) with high transfection efficiency were designed and synthesized as nonviral gene delivery vectors. The polycations were synthesized by Michael addition copolymerization of N,N-dimethylaminodipropylenetriamine (DMDPTA) and two bisacrylamide monomers N,N'-hexamethylene bisacrylamide (HMBA) and N,N'-cystamine bisacrylamide (CBA). The density of disulfide linkages in the synthesized hyperbranched polymers was tuned by varying the feed molar ratio of the bisacrylamide monomers. The results demonstrate that disulfide content in RHB controls the molecular weight of the polycation degradation products, ease of polyplex disassembly, polycation cytotoxicity, and polyplex transfection activity. Due to their lower cytotoxicity, polyplexes based on reducible polycations could be used safely in a wider range of DNA doses than nonreducible controls. As a result, significantly increased transfection activity is achieved with optimized formulations of reducible polyplexes compared with nonreducible controls.
Cationic Polymers as Transfection Reagents for Nucleic Acid Delivery.
Cai X, Dou R, Guo C, Tang J, Li X, Chen J Pharmaceutics. 2023; 15(5).
PMID: 37242744 PMC: 10223806. DOI: 10.3390/pharmaceutics15051502.
Poly(β-amino ester)s-based nanovehicles: Structural regulation and gene delivery.
Zhang J, Cai X, Dou R, Guo C, Tang J, Hu Y Mol Ther Nucleic Acids. 2023; 32:568-581.
PMID: 37200860 PMC: 10185705. DOI: 10.1016/j.omtn.2023.04.019.
Sahoo R, Gupta T, Batheja S, Goyal A, Gupta U Curr Drug Metab. 2022; 23(9):708-722.
PMID: 35713127 DOI: 10.2174/1389200223666220616125524.
Disulfide-containing Macromolecules for Therapeutic Delivery.
Jiang Z, Thayumanavan S Isr J Chem. 2021; 60(1-2):132-139.
PMID: 34168383 PMC: 8221575. DOI: 10.1002/ijch.201900160.
Potential Applications of Nanomaterials and Technology for Diabetic Wound Healing.
Bai Q, Han K, Dong K, Zheng C, Zhang Y, Long Q Int J Nanomedicine. 2020; 15:9717-9743.
PMID: 33299313 PMC: 7721306. DOI: 10.2147/IJN.S276001.